• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表观遗传学在乳腺癌中的诊断效用——综述

Diagnostic utility of epigenetics in breast cancer - A review.

作者信息

Bhat Showkat Ahmad, Majid Sabhiya, Wani Hilal Ahmad, Rashid Samia

机构信息

Department of Biochemistry, Government Medical College, Srinagar, Jammu & Kashmir, India.

Department of Biochemistry, Government Medical College, Srinagar, Jammu & Kashmir, India.

出版信息

Cancer Treat Res Commun. 2019;19:100125. doi: 10.1016/j.ctarc.2019.100125. Epub 2019 Feb 19.

DOI:10.1016/j.ctarc.2019.100125
PMID:30802811
Abstract

Epigenetic alterations are clearly involved in cancer initiation and progression as recent epigenetic studies of genomic DNA, histone modifications and micro-RNA alterations suggest that these are playing an important role in the incidence of breast cancer. Epigenetic information has recently gained the attention of researchers because epigenetic modification of the genome in breast cancer is still an evolving area for researchers. Several active compounds present in foods, poisons, drugs, and industrial chemicals may as a result of epigenetic mechanisms increase or decrease the risk of breast cancer. Epigenetic regulation is critical in normal growth and development and closely conditions the transcriptional potential of genes. Epigenetic mechanisms convey genomic adaption to an environment thereby ultimately contributing towards given phenotype. In addition to the use of epigenetic alterations as a means of screening, epigenetic alterations in a tumor or adjacent tissues or peripheral blood may also help clinicians in determining prognosis and treatment of breast cancer. As we understand specific epigenetic alterations contributing to breast tumorigenesis and prognosis, these discoveries will lead to significant advances for breast cancer treatment, like in therapeutics that target methylation and histone modifications in breast cancer and the newer versions of the drugs are likely to play an important role in future clinical treatment.

摘要

表观遗传改变显然与癌症的发生和发展有关,因为最近对基因组DNA、组蛋白修饰和微小RNA改变的表观遗传学研究表明,这些改变在乳腺癌的发病中起着重要作用。表观遗传信息最近引起了研究人员的关注,因为乳腺癌中基因组的表观遗传修饰仍是研究人员不断探索的领域。食物、毒物、药物和工业化学品中存在的几种活性化合物可能通过表观遗传机制增加或降低患乳腺癌的风险。表观遗传调控在正常生长和发育中至关重要,并密切影响基因的转录潜能。表观遗传机制使基因组适应环境,从而最终促成特定的表型。除了将表观遗传改变用作筛查手段外,肿瘤、邻近组织或外周血中的表观遗传改变也可能帮助临床医生确定乳腺癌的预后和治疗方案。随着我们了解到导致乳腺肿瘤发生和预后的特定表观遗传改变,这些发现将推动乳腺癌治疗取得重大进展,例如针对乳腺癌中甲基化和组蛋白修饰的治疗方法,而新型药物可能在未来临床治疗中发挥重要作用。

相似文献

1
Diagnostic utility of epigenetics in breast cancer - A review.表观遗传学在乳腺癌中的诊断效用——综述
Cancer Treat Res Commun. 2019;19:100125. doi: 10.1016/j.ctarc.2019.100125. Epub 2019 Feb 19.
2
The epigenetics of breast cancer.乳腺癌的表观遗传学。
Mol Oncol. 2010 Jun;4(3):242-54. doi: 10.1016/j.molonc.2010.04.002. Epub 2010 Apr 29.
3
Epigenetic mechanisms of breast cancer: an update of the current knowledge.乳腺癌的表观遗传学机制:最新知识综述。
Epigenomics. 2014;6(6):651-64. doi: 10.2217/epi.14.59.
4
Epigenetics in Metastatic Breast Cancer: Its Regulation and Implications in Diagnosis, Prognosis and Therapeutics.转移性乳腺癌中的表观遗传学:其在诊断、预后和治疗中的调控作用及其意义。
Curr Cancer Drug Targets. 2019;19(2):82-100. doi: 10.2174/1568009618666180430130248.
5
Epigenetic alterations in the breast: Implications for breast cancer detection, prognosis and treatment.乳腺中的表观遗传改变:对乳腺癌检测、预后及治疗的意义。
Semin Cancer Biol. 2009 Jun;19(3):165-71. doi: 10.1016/j.semcancer.2009.02.007. Epub 2009 Feb 20.
6
Epigenetic inactivation of DNA repair in breast cancer.乳腺癌中 DNA 修复的表观遗传失活。
Cancer Lett. 2014 Jan 28;342(2):213-22. doi: 10.1016/j.canlet.2012.05.015. Epub 2012 May 23.
7
Epigenetics in breast cancer.乳腺癌中的表观遗传学
Exp Oncol. 2013 Dec;35(4):246-9.
8
Combinatorial epigenetic regulation of non-coding RNAs has profound effects on oncogenic pathways in breast cancer subtypes.组合表观遗传调控非编码 RNA 对乳腺癌亚型致癌途径有深远影响。
Brief Bioinform. 2018 Jan 1;19(1):52-64. doi: 10.1093/bib/bbw099.
9
Epigenetics of Breast Cancer: Clinical Status of Epi-drugs and Phytochemicals.乳腺癌的表观遗传学:Epi 药物和植物化学物质的临床现状。
Adv Exp Med Biol. 2019;1152:293-310. doi: 10.1007/978-3-030-20301-6_16.
10
Epigenetic biomarkers in colorectal cancer: premises and prospects.结直肠癌中的表观遗传生物标志物:前提与前景
Biomarkers. 2018 Mar;23(2):105-114. doi: 10.1080/1354750X.2016.1252961. Epub 2016 Nov 10.

引用本文的文献

1
Molecular profiling of breast cancer methylation pattern in triple negative versus non- triple negative breast cancer.三阴性乳腺癌与非三阴性乳腺癌的甲基化模式分子特征分析
Sci Rep. 2025 Feb 26;15(1):6894. doi: 10.1038/s41598-025-90150-9.
2
Hypermethylation of the Gene Body in Is Involved in Breast Cancer Cell Proliferation and Is a Potential Blood-Based Biomarker for Early Detection and a Poor Prognosis.基因体的过度甲基化与乳腺癌细胞增殖有关,并且是一种潜在的基于血液的早期检测和不良预后的生物标志物。
Biomolecules. 2024 May 12;14(5):571. doi: 10.3390/biom14050571.
3
hypomethylation as a biomarker for distinguishing benign and malignant breast tumours.
低甲基化作为区分良性和恶性乳腺肿瘤的生物标志物。
Epigenetics. 2024 Dec;19(1):2352683. doi: 10.1080/15592294.2024.2352683. Epub 2024 May 9.
4
TET Enzymes and 5hmC Levels in Carcinogenesis and Progression of Breast Cancer: Potential Therapeutic Targets.TET 酶和 5hmC 水平在乳腺癌发生和进展中的作用:潜在的治疗靶点。
Int J Mol Sci. 2023 Dec 24;25(1):272. doi: 10.3390/ijms25010272.
5
The association between methylation in peripheral blood and breast cancer in Chinese women.中国女性外周血甲基化与乳腺癌之间的关联。
Front Oncol. 2023 May 18;13:1148635. doi: 10.3389/fonc.2023.1148635. eCollection 2023.
6
identification and expression analysis of breast cancer-related mA-SNPs.鉴定和表达分析乳腺癌相关的 mA-SNPs。
Epigenetics. 2022 Dec;17(13):2144-2156. doi: 10.1080/15592294.2022.2111137. Epub 2022 Aug 29.
7
A DNA Methylation-Based Gene Signature Can Predict Triple-Negative Breast Cancer Diagnosis.一种基于DNA甲基化的基因特征可预测三阴性乳腺癌诊断。
Biomedicines. 2021 Oct 4;9(10):1394. doi: 10.3390/biomedicines9101394.
8
Impact of Stilbenes as Epigenetic Modulators of Breast Cancer Risk and Associated Biomarkers.白藜芦醇作为乳腺癌风险和相关生物标志物的表观遗传调节剂的影响。
Int J Mol Sci. 2021 Sep 17;22(18):10033. doi: 10.3390/ijms221810033.
9
Peripheral Blood Leukocyte N6-methyladenosine is a Noninvasive Biomarker for Non-small-cell Lung Carcinoma.外周血白细胞N6-甲基腺苷是一种用于非小细胞肺癌的无创生物标志物。
Onco Targets Ther. 2020 Nov 19;13:11913-11921. doi: 10.2147/OTT.S267344. eCollection 2020.
10
Association of HDAC8 Expression with Pathological Findings in Triple Negative and Non-Triple Negative Breast Cancer: Implications for Diagnosis.组蛋白去乙酰化酶 8 表达与三阴性和非三阴性乳腺癌病理结果的关联:对诊断的启示。
Iran Biomed J. 2020 Sep;24(5):288-94. doi: 10.29252/ibj.24.5.283. Epub 2020 May 2.